Efficacy of artesunate-amodiaquine and artemether-lumefantrine fixed-dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria among children aged six to 59 months in Nimba County, Liberia: an open-label randomized non-inferiority trial

[1]  E. Ashley,et al.  Tolerability and safety of artesunate-amodiaquine and artemether-lumefantrine fixed dose combinations for the treatment of uncomplicated Plasmodium falciparum malaria: two open-label, randomized trials in Nimba County, Liberia , 2013, Malaria Journal.

[2]  F. Nosten,et al.  Emergence of artemisinin-resistant malaria on the western border of Thailand: a longitudinal study , 2012, The Lancet.

[3]  P. Guérin,et al.  Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: a randomized non-inferiority trial , 2012, Malaria Journal.

[4]  A. Dash,et al.  Artesunate-amodiaquine fixed dose combination for the treatment of Plasmodium falciparum malaria in India , 2012, Malaria Journal.

[5]  Renuka Kunte,et al.  WHO Guidelines for the treatment of malaria , 2011 .

[6]  B. Cissé,et al.  Repeated treatment of recurrent uncomplicated Plasmodium falciparum malaria in Senegal with fixed-dose artesunate plus amodiaquine versus fixed-dose artemether plus lumefantrine: a randomized, open-label trial , 2011, Malaria Journal.

[7]  A. Rasheed,et al.  Efficacy and safety of artemehter-lumefantrine in uncomplicated falciparum malaria in Liberia. , 2011, JPMA. The Journal of the Pakistan Medical Association.

[8]  Lorenz von Seidlein,et al.  Artemisinin resistance: current status and scenarios for containment , 2010, Nature Reviews Microbiology.

[9]  J. Ndiaye,et al.  Efficacy and tolerability of artesunate‐amodiaquine (Camoquin plus®) versus artemether‐lumefantrine (Coartem®) against uncomplicated Plasmodium falciparum malaria: multisite trial in Senegal and Ivory Coast , 2010, Tropical medicine & international health : TM & IH.

[10]  R. Price,et al.  In vivo parasitological measures of artemisinin susceptibility. , 2010, The Journal of infectious diseases.

[11]  Icf Macro.  Liberia Malaria Indicator Survey 2009 , 2009 .

[12]  J. Ndiaye,et al.  Efficacy of artesunate-amodiaquine for treating uncomplicated falciparum malaria in sub-Saharan Africa: a multi-centre analysis , 2009, Malaria Journal.

[13]  Paul Garner,et al.  Artemisinin-based combination therapy for treating uncomplicated malaria. , 2009, The Cochrane database of systematic reviews.

[14]  P. Houzé,et al.  Comparison of sulfadoxine-pyrimethamine, unsupervised artemether-lumefantrine, and unsupervised artesunate-amodiaquine fixed-dose formulation for uncomplicated plasmodium falciparum malaria in Benin: a randomized effectiveness noninferiority trial. , 2009, The Journal of infectious diseases.

[15]  J. Ndiaye,et al.  Randomized, multicentre assessment of the efficacy and safety of ASAQ – a fixed-dose artesunate-amodiaquine combination therapy in the treatment of uncomplicated Plasmodium falciparum malaria , 2009, Malaria Journal.

[16]  J. Keiser,et al.  A single LC-tandem mass spectrometry method for the simultaneous determination of 14 antimalarial drugs and their metabolites in human plasma. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[17]  L. Gustafsson,et al.  Field-adapted sampling of whole blood to determine the levels of amodiaquine and its metabolite in children with uncomplicated malaria treated with amodiaquine plus artesunate combination , 2009, Malaria Journal.

[18]  S. Sirima,et al.  The efficacy and safety of a new fixed-dose combination of amodiaquine and artesunate in young African children with acute uncomplicated Plasmodium falciparum , 2009, Malaria Journal.

[19]  M. Fukuda,et al.  Evidence of artemisinin-resistant malaria in western Cambodia. , 2008, The New England journal of medicine.

[20]  R. Price,et al.  Simplified antimalarial therapeutic monitoring: using the day-7 drug level? , 2008, Trends in parasitology.

[21]  F. Nosten,et al.  Artemisinin-based combination treatment of falciparum malaria. , 2007, The American journal of tropical medicine and hygiene.

[22]  D. Blessborn,et al.  Development and validation of an automated solid-phase extraction and liquid chromatographic method for determination of lumefantrine in capillary blood on sampling paper. , 2007, Journal of pharmaceutical and biomedical analysis.

[23]  C. Whitty,et al.  Artemisinin-based combination treatment for malaria in Africa: no perfect solutions. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[24]  Abdullah S. Ali,et al.  Efficacy of artesunate plus amodiaquine versus that of artemether-lumefantrine for the treatment of uncomplicated childhood Plasmodium falciparum malaria in Zanzibar, Tanzania. , 2005, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.

[25]  F. Checchi,et al.  High Plasmodium falciparum resistance to chloroquine and sulfadoxine-pyrimethamine in Harper, Liberia: results in vivo and analysis of point mutations. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[26]  F. Checchi,et al.  Efficacy of amodiaquine for uncomplicated Plasmodium falciparum malaria in Harper, Liberia. , 2002, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[27]  C. Karema,et al.  A Head-to-Head Comparison of Four Artemisinin-Based Combinations for Treating Uncomplicated Malaria in African Children: A Randomized Trial , 2011 .

[28]  Organización Mundial de la Salud.  Guidelines for the treatment of malaria , 2010 .

[29]  Organización Mundial de la Salud.  Methods and techniques for clinical trials on antimalarial drug efficacy: genotyping to identify parasite populations , 2008 .